buy chinese digital currency, Featured snippets

Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.Contemporary Amperex Technology Co., Limited applied for the trademark of "Chargeo Charging Dog", and the intellectual property information of Tianyancha shows that recently, Contemporary Amperex Technology Co., Limited New Energy Technology Co., Ltd. applied for the registration of three trademarks of "Chargeo Charging Dog", which are internationally classified as transportation, scientific instruments and building repair, and the current trademark status is awaiting substantive examination. According to media reports, "CharGo charging dog" is a storage, charging and inspection integrated robot developed by Contemporary Amperex Technology Co., Limited. The charging dog has three functions in one. It is not only a mobile charging facility, but also a distributed energy storage, and it is also a battery safety guardian of new energy vehicles.The yield of China's 30-year national debt "24 Special National Debt 06" fell below 2%, hitting a new low.

CEO of Cloud Whale Intelligence responded to layoffs: In order to optimize the organizational structure, it was streamlined from 1,600 to 1,400. Zhang Junbin, CEO of Cloud Whale Intelligence, recently issued a statement in a circle of friends, responding to previous reports of layoffs: "The company's personnel adjustment is to optimize the organizational structure and improve organizational efficiency." According to Zhang Junbin, the company was downsized from the original 1,600 to 1,400, which was not a large-scale layoff. Previously, a number of insiders and employees of Cloud Whale Intelligence revealed to Sina Technology that the company has recently started a major layoff. This round of layoffs involves a wide range of business departments, including development departments, testing departments, etc., and in groups, some groups directly cut their staff by half, and extreme groups cut their staff by 65%. In addition, the company's 12 director-level leaders, three of whom left in the past year, "is very mobile." (Sina Technology)On the 13th, the European futures of the container freight index rose by 7.03%, and the latest main contract positions changed as follows. According to the data of the exchange, as of December 13th, the European futures of the main contract container freight index closed at 2502, up or down by +7.03%, with a turnover of 41,900 lots. The position data showed that the top 20 seats were net, and the difference position was 3,022 lots. A total of 78,900 lots of European futures contracts were traded, an increase of 8,599 lots over the previous day. The first 20 seats in the contract held 25,100 lots, an increase of 466 lots over the previous day. The short positions in the top 20 seats of the contract were 22,100 lots, a decrease of 120 lots from the previous day. (Sina Futures) 

Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.Clown won the TGA Best Indie Game Award.Tesla China will launch advanced intelligent summoning ASS function for vehicles with EAP or FSD. On December 13th, Tesla China official website launched a brand-new vehicle function-Actually Smart Summon. This function is suitable for Tesla vehicles with EAP (enhanced automatic driving assistance function) or FSD (full automatic driving capability). Tesla owners can automatically park the vehicle from the parking space and drive to the owner's side or the location designated by the owner on the mobile phone by operating on the Tesla application of the mobile phone, and the vehicle needs to be kept within the owner's sight during the moving process. It is reported that this function will be pushed to the owner through OTA remote software update function.